SCHEMBL7711733

SCHEMBL7711733

Nc1cc(-c2cccc(C(F)(F)F)c2)cc(N)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.53
▸ ADORA1 P30542 2/20 0.53
▸ TSHR P16473 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ XDH P47989 1/20 0.51
▸ IKBKB O14920 1/20 0.49
▸ PGR P06401 1/20 0.49
▸ BRD4 O60885 1/20 0.49
▸ MAOB P27338 1/20 0.49
▸ KDM1A O60341 2/20 0.47
▸ CTSS P25774 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ NOTUM Q6P988 2/20 0.46
▸ KIF11 P52732 1/20 0.46
▸ IDO1 P14902 1/20 0.46
▸ PARP1 P09874 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28946840 0.84 ADORA2A (0.51) ADORA2AADORA1TSHRMAPK1XDH
SCHEMBL29678302 0.82 TSHR (0.58) TSHRMAPK1PGRMAOBKDM1A
SCHEMBL1263144 0.82 TSHR (0.58) TSHRMAPK1PGRMAOBKDM1A
SCHEMBL1358158 0.80 XDH (0.57) ADORA2AADORA1TSHRMAPK1XDH
Ammonia Solution, Strong SCHEMBL20472961 0.80 MAOB (0.56) TSHRMAPK1PGRMAOBKDM1A
SCHEMBL27978518 0.79 TSHR (0.70) ADORA2AADORA1TSHRMAPK1XDH
SCHEMBL6256565 0.79 CTSS (0.60) ADORA2AADORA1TSHRMAPK1XDH
SCHEMBL7703168 0.79 KIF11 (0.59) IKBKBMAOBKIF11
SCHEMBL3789224 0.79 TSHR (0.76) ADORA2AADORA1TSHRMAPK1XDH
SCHEMBL30704262 0.77 MAP4K4 (0.62) ADORA2AADORA1TSHRMAPK1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 — — US disclosed
Send feedback